Landscape Capital Management L.L.C. bought a new position in shares of Steris PLC (NYSE:STE) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 30,328 shares of the medical equipment provider’s stock, valued at approximately $4,515,000.

A number of other large investors have also bought and sold shares of the stock. Ropes Wealth Advisors LLC acquired a new position in shares of Steris in the 2nd quarter worth approximately $26,000. Evolution Wealth Advisors LLC acquired a new position in shares of Steris in the 2nd quarter worth approximately $27,000. Farmers & Merchants Investments Inc. acquired a new position in shares of Steris in the 2nd quarter worth approximately $33,000. Cullen Frost Bankers Inc. lifted its position in shares of Steris by 114.4% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 253 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 135 shares during the period. Finally, Financial Gravity Wealth Inc. lifted its position in shares of Steris by 10,733.3% in the 2nd quarter. Financial Gravity Wealth Inc. now owns 325 shares of the medical equipment provider’s stock worth $48,000 after purchasing an additional 322 shares during the period. Institutional investors and hedge funds own 85.45% of the company’s stock.

A number of brokerages have recently issued reports on STE. Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $146.00 price target on the stock in a research report on Tuesday, April 30th. KeyCorp boosted their price target on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Stephens boosted their price target on shares of Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th. Finally, JMP Securities boosted their price target on shares of Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a research report on Wednesday, May 22nd. Five analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and a consensus target price of $148.20.

Shares of NYSE STE traded up $0.59 during midday trading on Thursday, reaching $152.28. The stock had a trading volume of 13,807 shares, compared to its average volume of 416,884. The firm has a 50 day simple moving average of $149.82. The company has a market cap of $12.81 billion, a price-to-earnings ratio of 31.16 and a beta of 0.98. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.87 and a current ratio of 2.41. Steris PLC has a twelve month low of $99.14 and a twelve month high of $156.12.

Steris (NYSE:STE) last released its quarterly earnings data on Monday, August 5th. The medical equipment provider reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.12. The company had revenue of $696.80 million during the quarter, compared to analyst estimates of $674.12 million. Steris had a net margin of 11.22% and a return on equity of 13.80%. Steris’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.00 EPS. On average, equities research analysts expect that Steris PLC will post 5.45 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Tuesday, September 10th will be paid a $0.37 dividend. The ex-dividend date is Monday, September 9th. This represents a $1.48 annualized dividend and a dividend yield of 0.97%. This is a positive change from Steris’s previous quarterly dividend of $0.34. Steris’s payout ratio is currently 27.81%.

In other Steris news, CEO Walter M. Rosebrough, Jr. sold 119,000 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $132.56, for a total transaction of $15,774,640.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Karen L. Burton sold 1,387 shares of the business’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $133.89, for a total transaction of $185,705.43. The disclosure for this sale can be found here. Insiders sold a total of 355,286 shares of company stock valued at $50,048,013 in the last quarter. 2.36% of the stock is currently owned by company insiders.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: What is a Candlestick Chart?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.